Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.120 | 4 | 122151854 | upstream gene variant | T/C | snv | 0.24 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.807 | 0.280 | 4 | 122297158 | intron variant | A/G | snv | 0.10 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.800 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.807 | 0.280 | 4 | 122297158 | intron variant | A/G | snv | 0.10 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.807 | 0.280 | 4 | 122297158 | intron variant | A/G | snv | 0.10 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.807 | 0.280 | 4 | 122297158 | intron variant | A/G | snv | 0.10 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.807 | 0.280 | 4 | 122297158 | intron variant | A/G | snv | 0.10 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.827 | 0.200 | 4 | 122194347 | intron variant | A/G | snv | 0.11 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.827 | 0.200 | 4 | 122194347 | intron variant | A/G | snv | 0.11 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.827 | 0.200 | 4 | 122194347 | intron variant | A/G | snv | 0.11 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.827 | 0.200 | 4 | 122194347 | intron variant | A/G | snv | 0.11 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.827 | 0.200 | 4 | 122194347 | intron variant | A/G | snv | 0.11 |
|
Immune System Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.080 | 4 | 122194117 | intron variant | C/G;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
4 | 122262050 | intron variant | A/C;G | snv | 0.13 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||||
|
4 | 122262050 | intron variant | A/C;G | snv | 0.13 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||||
|
4 | 122179956 | intron variant | T/C | snv | 0.13 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||||
|
4 | 122179956 | intron variant | T/C | snv | 0.13 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||||
|
0.776 | 0.400 | 4 | 122211337 | intron variant | A/G | snv | 0.29 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.776 | 0.400 | 4 | 122211337 | intron variant | A/G | snv | 0.29 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Skin and Connective Tissue Diseases; Stomatognathic Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.776 | 0.400 | 4 | 122211337 | intron variant | A/G | snv | 0.29 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.776 | 0.400 | 4 | 122211337 | intron variant | A/G | snv | 0.29 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.776 | 0.400 | 4 | 122211337 | intron variant | A/G | snv | 0.29 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.776 | 0.400 | 4 | 122211337 | intron variant | A/G | snv | 0.29 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.776 | 0.400 | 4 | 122211337 | intron variant | A/G | snv | 0.29 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.800 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.040 | 4 | 122265238 | intron variant | A/G | snv | 3.3E-02 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
4 | 122263672 | intron variant | G/A | snv | 0.16 |
|
0.700 | 1.000 | 1 | 2016 | 2016 |